Kardigan (KARD)
Develops cardiovascular therapies through biologically defined, data-enabled clinical trials.
$21.82
At close+2.22 (+11.33%)
Something off on this page? Send us feedback.
EPSReportedEstimate
——————May '26Aug '26
Reported——————−$1.43−$2.88
Estimate———————−$0.68
Surprise———————−326.5%
RevenueReportedEstimate
——————May '26Aug '26
Reported————————
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | −$0.68 | −$2.88 | −326.5% |
| May 2026 | — | −$1.43 | — |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | −$0.68 | −$2.88 | −326.5% | — | — | — | +4.7% |
| May 26, 2026 | — | −$1.43 | — | — | — | — | — |